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Protein restriction during rodent pregnancy is a well-established model of developmental 
programming. Although the Southampton low-protein diet model of developmental 
programming has been accepted to produce hypertensive offspring, the mechanism of this 
programming remains unclear. Currently the effects of protein restriction in the Southampton 
low-protein diet are confounded by a relative elevation of the amino acid methionine. The aim of 
this project was thus to clarify the roles of protein reduction and methionine elevation within this 
model, especially within the context of amino acid and one-carbon metabolism. Pregnant Wistar 
rats were fed casein-based diets ad libitum varying in casein (18% or 9%) and methionine 
content (0.5% or 1.0%) from day 0 through 20 of pregnancy. Two diets exactly replicated the 
Southampton control and low-protein diets (Con: 18% casein, 0.5% methionine; LP: 9% casein, 
0.5% methionine), while a third low-protein high-methionine diet (LP-MET: 9% casein, 1.0% 
methionine) was employed as a positive control for methionine stress. On day 20 of gestation 
dams were sacrificed and the feto-placental unit was excised; maternal and fetal blood was 
collected for HPLC analysis of free amino acids. Maternal plasma was also analyzed for 
homocysteine content using a spectrophotometric-based enzyme assay. Diet did not affect 
maternal weight gain, food consumption, litter size or fetal weight. In dams and fetuses, 
methionine was significantly elevated in both low-protein groups. Maternal homocysteine was 
significantly elevated only in dams fed the low-protein high-methionine diet. Reductions in 
maternal serine, proline and glycine levels also occurred in dams fed the low-protein high-
methionine diet; fetuses of these dams had significantly reduced levels of all three branch chain 
amino acids (leucine, isoleucine and valine). Both low-protein diets resulted in drastic reductions 
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in circulating threonine levels in dams and fetuses.  Thus, ingestion of low-protein diets with a 
relative (0.5%) or overt excess (1.0%) of methionine appears to disrupt one-carbon metabolism 
at the level of homocysteine remethylation to methionine. This may place strain on the folate 
cycle, as may be indicated by the reduced levels of threonine, serine and glycine. Further testing 
is necessary to clarify the extent to which folate stores are being utilized for homocysteine 
remethylation. Increased competition for placental amino acid transport may explain the 
alternations in circulating free fetal amino acids. Further investigations into levels of other one-
carbon metabolites in dams and fetuses are necessary to fully characterize the effect of low-
protein high-methionine diets, particularly within the context of the Southampton model of 
developmental programming.   
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1.1 Developmental Origins of Health and Disease Hypothesis (DOHaD) 
In human populations associations exist between low-birth weight and an increased 
susceptibility to the metabolic syndrome- a collection of pathological metabolic disturbances 
(dyslipidemias, insulin resistance, visceral obesity, elevated blood pressure) that collectively 
promote development of diabetes and/ or cardiovascular diseases (Gluckman & Hanson 2004). 
Formulated from these data, the developmental origins of health and disease (DOHaD) 
hypothesis states a causal relationship exists between metabolic and physiologic adaptations 
occurring in utero and long-term post-natal health. Moreover, it is the uterine environment which 
induces these adaptations. Termed as ‘reprogramming events’ these adaptations are permanent, 
serving adaptive purposes when the uterine and post-natal environments match. In contrast, 
reprogramming becomes maladaptive, creating an increased predisposition to development of 
chronic disease(s), when the pre- and post-natal environments differ, as the individual is not 
optimally equipped metabolically or physiologically to cope with the post-natal environment 
(Barker 2007, Langley-Evans 2006). For example, adaptation to a nutritionally bereft uterine 
environment would confer advantages to surviving post-natal nutritional scarcity, but would be 
maladaptive in a nutritionally plentiful environment (Gluckman & Hanson 2004).   
To unravel the mechanism(s) behind fetal reprogramming, numerous experimental 
approaches (genetic or dietary manipulation, uterine artery ligation, or administration of 
pharmacological agents) in many animal species (rats, mice, guinea pigs, sheep) have been 
employed (Langley-Evans et al. 2005, Bertram & Hanson 2001). It is interesting that the 
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divergent insults delivered in these models tend to elicit similar phenotypic outcomes – 
specifically, hypertension, glucose intolerance and insulin resistance in the offspring (Langley-
evans 2004).    
1.2 Rat Low-Protein Diet Model of Developmental Reprogramming 
Two paradigms of dietary manipulation, global nutrient restriction or iso-caloric protein 
restriction, also referred to as maternal low protein diet, have been developed (Bertram & 
Hanson 2001). The rodent maternal low protein paradigm is a well-established model of 
developmental programming. In this model pregnant rats are fed casein-based iso-caloric low 
protein diets (LPDs) commencing on day 0 of pregnancy. Two such LPDs, the Southampton and 
Hope Farms diets, have been shown to result in differential reprogramming; the former diet 
consistently reprograms for hypertensive offspring (Langley-Evans 2006) while the latter results 
in offspring with impaired glucose and insulin metabolism (Ozanne & Hales 2002, Hoet et al. 
2000). These discrepant results hold true even when testing using identical feeding regimens, 
identical rat strains and methodological techniques (Langley-Evans 2000). Both the 
Southampton and Hope Farms LPDs contain identical levels of protein (Appendix A and Table 
1). Thus dietary protein reduction may not underlie Southampton-LPD mediated hypertension.  
The Southampton and Hope Farms diets differ markedly in the overall content and source of 
carbohydrate and fat, as well as in the level of supplemental DL-methionine (Appendix A and 
Table 1) (Langley-Evans 2000).  
Correction of the inherent sulfur-amino acid deficiency (specifically cysteine) of casein is 
typically achieved by supplementation with methionine, which can be metabolically converted to 
cysteine (Reeves et al. 1993). Indeed, sulfur-supplementation of such casein-based diets is 
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especially critical during rat pregnancy as casein, containing 0.3% cysteine and 2.3% 
methionine, supplies less than half the sulfur required by the pregnant rat. However, methionine 
is the most toxic of all 20 amino acids when present in excess (Muramatsu et al. 1971, 
Sauberlich 1961), affecting parameters such as body growth (Matsueda & Niiyama 1982), 
methylation reactions (Dong et al. 2005) and cardiovascular health (Troen et al. 2003) all of 
which show impairment in the Southampton model of developmental programming (Langley-
Evans 2006). To avoid such methionine toxicity in 1993 the American Institute of Nutrition 
(AIN), a committee formed specifically to address the nutritional needs of laboratory rodents, 
began recommending supplementation of casein-based diets with cystine rather than methionine 
(Reeves et al. 1993). The Southampton diets do not adhere to this recommendation, instead 
following AIN 1976 guidelines. It is noteworthy then that the Southampton LPD supplies 
respectively 2.5 and 6-fold more methionine than the Hope Farms control and LPD, and 2-fold 
more methionine (relative to total dietary protein) than the Southampton control diet. Thus 
methionine may be one agent involved in the programming of hypertension observed with the 
Southampton LPD (Langley-Evans 2000). 
Table 1: Critical differences in the Southampton and Hope Farms Diets 
 Southampton Diet Hope Farms Diet 
(g/100 g diet) Control LPD Control LPD 
Casein 18.0 9.0 18.0 9.0 
DL-Methionine 0.5 0.5 0.2 0.08 
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1.3 The Amino Acid Methionine 
Methionine, an essential sulfur-amino acid plays a central role in one-carbon (1-C) 
metabolism (Figure 1), encompassing the folate and methionine cycles, in which a single carbon 
moiety is transferred between two molecules (Cho et al. 2007). 1-C metabolism contributes to 
the synthesis of purine subunits for the synthesis of DNA, while also governing epigenetic 
regulation of gene expression, specifically through the 1-C metabolite S-adenosylmethionine 
(AdoMet) (Friso & Choi 2005). Additionally, AdoMet contributes to the synthesis of the 
polyamines spermidine and spermine (Chiang et al. 1996), molecules which aid in cellular 
proliferation and in maintenance of structural integrity of DNA (Abraham 1981).  Proper 1-C 
metabolism is thus of critical importance during gestation while long-term methylation patterns 
are established and organogenesis occurs (Bauchart-Thevret et al. 2009, Kim et al. 2009). 
Additionally, 1-C metabolism interconnects with the transsulfuration pathway, through which the 
sulfur-containing amino acid cysteine is synthesized (Finkelstein 2000). Furthermore, 
metabolism of betaine (and its upstream metabolite choline) also connects with 1-C metabolism 
via the methionine cycle. Betaine/ choline metabolism is essential for proper cell signaling, 
structural integrity of membranes, cholinergic neurotransmission and hepatic lipid transport. 
Truly the disruption of 1-C metabolism could have profound impacts on physiology and 




Figure 1: Mammalian Methionine Metabolism 
Key reactions that prevent accumulation of homocycteine (Hcy) are represented by numbers 7, 6 
and 4.  The methionine cycle: reactions 1, 2, 3, 6, 7. AdoMet-dependent transmethylation: 
reaction 2. Transsulfuration: reactions 4 and 5. Choline/Betaine metabolism: reaction 6.  The 
folate cycle: reactions 7, 8, 9, 10.  
Numbers represent enzymes or reactions as follows: 1, Methionine adenosyltransferase (EC 
2.5.1.6). 2, AdoMet-dependent transmethylation. 3, S-adenosylhomocysteine hydrolase (EC 
3.3.1.1). 4, Cystathionine β synthase (CBS, EC 4.2.1.22). 5, γ-Cystathionase (EC 4.4.1.1). 6, 
Betaine-homocysteine methyltransferase (EC 2.1.1.5). 7, Methionine synthase/ Methylfolate-
homocysteine methyltransferase (EC 2.1.1.13). 8, Serine Hydroxymethyltransferase (EC 
2.1.2.1). 9, Glycine cleavage system (EC 2.1.2.10). 10, Methylenetetrahydofolate reductase (EC 
1.7.99.5).  





1.4 The Methionine Cycle 
Upon ingestion, methionine not used for protein synthesis enters the methionine cycle 
(Figure 1), a cycle which is present in all living cells. The first enzyme of this cycle, methionine 
adenosyltransferase (MAT), is responsible for the energy-dependent conversion of methionine to 
AdoMet (Figure 1 Reaction 1). MAT exists in three isoforms, each of which has distinct kinetic 
properties. Notably, only MATIII, the hepatic MAT isoform, is capable of responding to 
increased methionine concentrations with increased activity (Finkelstein 1998). AdoMet is a key 
biological molecule; it serves as the universal methyl donor for cellular transmethylation 
reactions (such as methylation of DNA and proteins) (Ulrey et al. 2005) or may be 
decarboxylated to form the precursor for spermine and spermidine biosynthesis (Finkelstein 
1990). In the case of intracellular transmethylation reactions, after methyl group donation S-
adenosylhomocysteine (AdoHcy) is generated from AdoMet (Figure 1 Reaction 2)  (Finkelstein 
2000). 
Because it provides potent allosteric inhibition of intracellular transmethylases, levels of 
AdoHcy must be tightly regulated within the cell, a feat achieved by three different mechanisms 
(Hoffman et al. 1980, Finkelstein 2000). The first mechanism is the binding of free cytosolic 
AdoHcy via cytosolic proteins (Svardal & Ueland 1987). The second mechanism involves 
AdoHcy hydrolysis by S-adenosylhomocysteine hydrolase (SAHH), forming homocysteine 
(Figure 1 Reaction 3). This reaction however relies upon prompt removal of homocysteine and 
adenosine from the cell, as SAHH is capable of operating in either the forward (formation of 
Hcy) or reverse (formation of AdoHcy) direction, and it is the reverse direction which is 
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favoured thermodynamically (De La Haba & Cantoni 1959). Thirdly, AdoHcy entering the 
systemic circulation will be cleared by the kidneys (Duerre et al. 1969, Walker & Duerre 1975). 
Homocysteine, formed exclusively from AdoHcy, may be re-methylated by either of two 
methyltransferases, betaine homocysteine methyltransferase (BHMT) (Figure 1 Reaction 6) or 
methylfolate-homocysteine methyltransferase (MFMT) (Figure 1 Reaction 7), with MFMT 
representing the intersection of the methionine and folate cycles (Figure 1) (Tibbetts & Appling 
2010). BHMT relies on betaine, derived from choline metabolism, as a methyl donor while 
MFMT utilizes methyl-tetrahydrofolate (methyl-THF). While MFMT is ubiquitously expressed 
in all the cells of the body, expression of BHMT is restricted to the mammalian liver, and also, 
the  kidneys of primates and pigs (Finkelstein 2000). Remethylation of Hcy leads to the 
reconstitution of methionine, and thus does not serve to eliminate methionine/ Hcy from the cell. 
Permanent removal of Hcy/ methionine from the cell is accomplished via a process called 
transsulfuration (Figure 1 Reactions 4,5). During transsulfuration, the heme-containing pyridoxal 
phosphate-dependent enzyme cystathionine beta synthase (CBS) irreversibly, via a serine-
dependent condensation reaction, converts Hcy to cystathionine (Figure 1 Reaction 4) 
(Oliveriusová et al. 2002), which can be used for the eventual synthesis of cysteine, taurine or 
glutathione (GSH) (Rees et al. 2006c). Transsulfuration is limited to occurrence in specific 
mammalian tissues, the small intestine, kidney, pancreas and liver, owing to the tissue specific 
expression of the principle enzyme in the pathway, CBS (Finkelstein 2000). Importantly, 
methionine/ Hcy may be cleared from all cells of the body despite the tissue-specific expression 
of CBS, as Hcy can be transported across the plasma membrane into the systemic circulation to 
one of the sites of transsulfuration (Svardal et al. 1986). 
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1.5 Disruption of the Methionine Cycle and One-Carbon Metabolism 
1.5.1 Methionine and DNA Methylation 
Epigenetics encompasses the study of heritable changes in gene expression that do not 
stem from alterations in the nucleotide sequence, but rather occur via reversible covalent 
modifications of the DNA itself, or of the histone proteins which bind DNA (Egger et al. 2004). 
Cytosine residues located in CpG-islands within the DNA may undergo methylation or 
demethylation, respectively repressing or activating transcription, and thus gene expression 
(Feinberg & Tycko 2004). Such epigenetic modifications allow for tissue and developmentally 
specific expression of genes. Thus during the highly plastic stage of development in utero during 
which cellular differentiation and organogenesis are occurring, an exceptionally high frequency 
of epigenetic events necessarily occur (Lillycrop et al. 2005). Impairment of proper methylation, 
resulting in hyper- or hypo-methylated DNA has been implicated in various disease states 
ranging from cancers and cardiovascular diseases to neuropsychiatric disorders (Rodenhiser & 
Mann 2006).  
Formed by the adenylation of methionine (Figure 1 Reaction 1), AdoMet is the ultimate 
intracellular methyl donor. Various intracellular transmethylases perform methyl transfer from 
AdoMet to co-substrates such as protein, phospholipids, neurotransmitters, RNA and DNA 
(Mato et al. 1997). Following methyl transfer AdoHcy is formed from AdoMet (Figure 1 
Reaction 2). AdoHcy potently inhibits most methylation reactions as AdoHcy binds to the active 
site of most methyltransferases with a much higher affinity than that of AdoMet (Hoffman et al. 
1979). Thus the ratio of AdoMet: AdoHcy is regarded as an indicator of a tissue’s methylation 
capacity, with increased and decreased ratios reflecting probable hyper- and hypo-methylation 
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respectively (Waterland 2006). Studies have shown an association between a skewed AdoMet: 
AdoHcy ratio to aberrant methylation patterns, however, it is noteworthy that only a rough 
indication of the methylation capacity of any given tissue is provided by this ratio (Yi et al. 
2000, Caudill et al. 2001, Tremolizzo et al. 2002). Furthermore, although either an increase in 
AdoHcy or a decrease in AdoMet create the potential of hypomethylation, it is thought that the 
former rather than the latter is more likely to result in aberrant methylation patterns (Caudill et 
al. 2001).  
1.5.2 Homocysteine 
Unavailable from dietary sources, Hcy is a sulfur-containing amino acid formed via the 
reversible removal of adenosine from AdoHcy by SAHH (Figure 1 Reaction 3). Irreversible 
methylation of Hcy to methionine by MFMT represents the intersection of the folate and 
methionine cycles, as the necessary methyl group is provided by methyl-tetrahydrofolate 
(methyl-THF) (Figure 1 Reaction 7) (Finkelstein 2000). Increases in Hcy levels (either via 
increased methionine intake or an increased frequency of transmethylation reactions) can 
precipitate a functional deficiency of cellular folates, a group of coenzyme factors essential for 
the transfer of 1-C units. Within this context, although dietary folate intake is ‘adequate’ by 
recommended standards, a deficiency is created by the metabolic status of the individual – more 
folate is needed to cope with an increased metabolic demand for Hcy remethylation than what is 
being ingested. Thus the organism becomes ‘functionally’ deficient. Additionally, the organism 
may become hyperhomocysteinemic, due to insufficient methyl-THF to re-methylate Hcy; 
excess Hcy may thus enter the systemic circulation resulting in hyperhomocysteinemia (Eskes 
1998, Brouwer et al. 1998).     
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Hyperhomocysteinemia, defined as elevated plasma or serum Hcy levels, has been 
associated with numerous adverse health conditions and events ranging from vascular diseases 
and acute vascular events to neurodegenerative disease and osteoporosis (Maron & Loscalzo 
2009). Additionally, hyperhomocysteinemia has been associated with increased risk of neural 
tube defects, pre-eclampsia and spontaneous abortions during pregnancy (Aubard et al. 2000).   
1.5.3 Methionine and Pregnancy 
1.5.3.1 Developmental Programming and DNA Methylation 
Provision of a diet that is unbalanced with respect to methionine has been shown to create 
epigenetic abnormalities (Pogribny et al. 2006, Pogribny et al. 2008, Jiang et al. 2007, Pogribny 
et al. 1995, Caudill et al. 2001). Such abnormalities would be especially detrimental if they were 
to occur during embryonic/ fetal development, potentially altering organ development. Aberrant 
methylation may be one of the mechanisms through which developmental programming of adult 
disease could occur during gestation (Langley-Evans 2006, Lillycrop et al. 2005). Indeed, a 
study performed by Rees et al. showed that feeding of a LPD containing 0.5% methionine to 
pregnant rats elicited global hypermethylation in fetal livers (Rees et al. 2000). In contrast in 
post-weaning offspring, Lillycrop et al. observed hepatic hypomethylation of the genes encoding 
the glucocorticoid receptor (GR) as well as the peroxisome proliferator receptor alpha (PPARα) 
(Lillycrop et al. 2005). Both the GR and PPARα genes have been posited to play a role in fetal 
programming of hypertension, cardiovascular disease and metabolic disorders (Rees et al. 
2006c). Additionally, changes in the transcript levels of DNA methyltransferase 1 (DNMT1), a 
methyltransferase responsible for epigenetic maintenance, were observed in what appeared to be 
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an age-diet and sex specific manner (Langley-Evans et al. 2006). Indeed, studies have shown 
differential programming of male and female offspring in response to an altered intra-uterine 
milieu. Amongst the results observed are gender-specific programming of post-natal 
cardiovascular physiology, metabolism and hypertension (Alexander 2006, Sugden & Holness 
2002). Notably, differential expression in a gender-specific manner of mRNA for many genes 
involved in mediating vascular function and glucose/insulin metabolism have been reported 
(Chamson-Reig et al. 2006, Kwong et al. 2007, O'Regan et al. 2004). Aberrant methylation 
patterns are known to alter gene transcription, and altered levels of AdoMet and AdoHcy are 
known to disrupt proper methylation (Feinberg & Tycko 2004, Waterland 2006). Thus the results 
of these studies strongly indicate possible increases in the levels of AdoHcy and subsequent 
disruption of 1-C metabolism. 
1.5.3.2 Developmental Programming and One-Carbon Metabolism 
Presently, disagreement exists in the literature as to whether dietary protein reduction or 
methionine elevation causes programming of hypertension in the Southampton model (Rees et 
al. 2006c, Langley-Evans et al. 2006). Indeed, while some studies have shown altered plasma 
Hcy levels in LPD-fed dams (Petrie et al. 2002), others have not (Langley-Evans et al. 2006, 
Engeham et al. 2010). Furthermore, direct measurement of the methyl-donors used for Hcy 
remethylation (folate, as well as the precursors to betaine: choline and phosphocholine) do not 
indicate increases in Hcy remethylation (Engeham et al. 2010). mRNA of MFMT and 
methylene-tetrahydrofolate reductase (MTHFR), key enzymes of the folate cycle respectively 
required for methyl-THF-dependent Hcy remethylation and regeneration of methyl-THF did not 
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differ from controls in LPD-exposed fetuses or dams (Langley-Evans et al. 2006, Engeham et al. 
2010). 
Table 2: Sulfur Amino Acids in the Southampton and Hope Farms Diets 
  Methionine Cystine 




g/kg diet % Estimated 
Requirement* 
Southampton 18 9.14 199 0.54 15 
9 7.07 155 0.27 7 
Hope Farms 22 7.06 153 0.54 15 
9 2.87 62 0.27 7 
*Values based on data from 1993 AIN recommendations for growth, pregnancy and lactation.  
 
However supplementation of the Southampton LPD with folate prevents programming 
(Lillycrop et al. 2005, Torrens et al. 2006, Engeham et al. 2010). Folate supplementation 
prevents LPD-associated promoter hypomethylation and increased expression of the GR and 
PPARα genes in LPD-exposed offspring (Lillycrop et al. 2005). Furthermore, LPD 
supplementation with folate or glycine, necessary co-substrates for the regeneration of 
methylene-THF (and thus methyl-THF) (Figure 1) prevents programming of hypertension 
(Jackson et al. 2002, Torrens et al. 2006) and improves LPD-associated vascular dysfunction 
(Brawley et al. 2004). Interestingly, programming of behaviour (a preference for fatty foods) 
results from folate supplementation of the Southampton control diet (Engeham et al. 2010). Thus 




Patterns of amino acids also suggest disruption of 1-C metabolism within the 
Southampton model. Indeed, plasma threonine concentrations show consistent and drastic 
reductions in both Southampton LPD-exposed dams and fetuses (Rees et al. 2006a, Petrie et al. 
2002, Rees et al. 1999, Rees et al. 2000). Interestingly, threonine levels rise in non-pregnant 
animals fed the Southampton LPD. Thus it seems pregnancy may increase threonine 
requirements (Rees et al. 2006a). Two major routes of threonine catabolism exist in mammals: 
catabolism via serine-threonine dehydratase (SDH) (top of Figure 2) or via threonine 
dehydrogenase (TDH) (bottom of Figure 2). Although the main activity of SDH is deamination 
of serine or threonine to their respective keto-acids (House et al. 2001), it may also catalyze the 
condensation of homocysteine and serine, yielding cystathionine (Selim & Greenberg 1959, 
Selim & Greenberg 1960, Goldstein et al. 1962). This CBS-like activity would link methionine 
and threonine metabolism, possibly explaining the threonine reduction observed with feeding 
high methionine diets (Daniel & Waisman 1969, Girard-Globa et al. 1972, Sanchez & 
Swendseid 1969).  
An alternate explanation for the threonine reduction could be increased catabolism of 
threonine via the enzyme TDH, to indirectly replenish methyl-THF (Rees et al. 2006a). TDH 
catabolizes threonine to glycine (House et al. 2001), one of the necessary co-substrates to 
produce methylene-THF (Friesen et al. 2007). It is commonly accepted that folate requirements 
increase during pregnancy (Antony 2007), and could further increase with ingestion of excess 
methionine. Direct measurement of TDH activity revealed no dietary effect (Rees et al. 2006a), 
however, changes in amino acids (glycine, serine) used to regenerate methylene-THF (the 
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precursor to methyl-THF) have been observed in dams (Petrie et al. 2002, Rees et al. 1999, Rees 
et al. 2000). 
 
 
Figure 2: Major pathways of threonine catabolism in mammals 
TDH: Threonine dehydrogenase (EC 1.1.1.103).  SDH: Serine-threonine dehydratase (EC 
4.3.1.19).  Note that controversy exists regarding the substrate specificity of the SDH enzyme. 
Some studies report deamination of serine and threonine to their corresponding keto acids to be 
the only reactions catalyzed by SDH; other studies have shown SDH capable of forming 
cystathionine via the condensation of serine and homocysteine. The possible cystathionine 
synthetase activity of SDH would link threonine catabolism to the methionine cycle and 
transsulfuration. Likewise, TDH activity is linked into one-carbon metabolism through 
generation of glycine, a necessary co-substrate used for regeneration of methylene THF in the 
folate cycle.  
 
While inconsistent effects on circulating Hcy have been reported (Petrie et al. 2002, 
Langley-Evans et al. 2006, Engeham et al. 2010), the current literature cites no dietary effect on 
maternal or fetal methionine levels (Petrie et al. 2002, Rees et al. 2006a, Rees et al. 2006b, Rees 
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et al. 1999). This apparent lack of change however may stem from adaptation during the two 
week dietary habituation period via increased hepatic methionine adenosyltransferase (MAT) 
activity, as has been shown to occur in other studies (Finkelstein & Martin 1986). Certainly, the 
signs of methionine toxicity (decreased birth weights and post-natal growth (Rees et al. 2006b, 
Rees et al. 2000), decreased fetal viability (Rees et al. 2006b)) as well as changes in gene 
expression and DNA methylation of fetuses (Rees et al. 2000, Langley-Evans et al. 2006) and 
pups (Lillycrop et al. 2005) point to the possibility of disrupted 1-C metabolism within this 
model.  
1.6 Research Objectives and Approach 
A primary research objective of this thesis was to determine whether the Southampton 
LPD alters one-carbon and amino acid metabolism in exposed dams and fetuses. Furthermore, 
clarification of the contribution of protein reduction and methionine elevation in this 
phenomenon was investigated through the use of an additional low-protein high-methionine diet 
(Table 3 and Appendix B). Replication of the Southampton control diet and LPD was achieved 
using a casein-based control and a casein-based methionine-elevated LPD.  
The impact of Southampton feeding on one-carbon metabolism, and the relative 
contributions of reduced protein and elevated methionine within this model was assessed through 
1) Analysis of free plasma amino acids in dams and fetuses via HPLC 




Following mating, females were weighed, transferred to a single cage and assigned to one 
of the three dietary treatment groups. Three purified, isocaloric diets using casein as the protein 
source (prepared by Teklad, see Appendix B) varied in casein content, methionine content and 
the protein to methionine ratio (Table 3 and Appendix B). Two diets were designed to replicate 
the Southampton control and LPD (CON/ 18-0.5 and LP/ 9-0.5 respectively). A second LPD 
(LP-MET/ 9-1.0) containing 1% methionine, an amount that has been shown to alter levels of 
key one-carbon metabolites and enzyme activities in other studies (Regina et al. 1993, Rowling 
et al. 2002, Finkelstein & Martin 1986), was employed to serve as a positive control for 
methionine stress. Diets were made iso-caloric by addition of sucrose and corn starch to the 9% 
LPDs (Appendix B).  
Table 3: Composition of Experimental Diets 
Diet % 
protein* 





18 0.5 36 18-0.5 
Low protein (LP) 9 0.5 18 9-0.5 
Low protein / high 
methionine (LP-
MET) 
9 1.0 9 9-1.0 
*All diets utilize casein as the sole protein source.   
 
 
Females were maintained on the experimental diets until euthanasia or delivery of pups. 
Food and water was available on an ad libitum basis; thus food consumption was monitored by 
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Objective: Maternal protein restriction during pregnancy is a well established model of 
developmental programming. Disruption of one-carbon metabolism via excess dietary 
methionine may underlie this model. The aim was to assess whether low-protein high-
methionine diets fed throughout pregnancy altered maternal and fetal amino acid profiles.  
Methods: Female Wistar rats were fed casein-based diets varying in protein and methionine 
content (control: 18% casein, 0.5% methionine; low protein: 9% casein, 0.5% methionine; low 
protein/ high methionine: 9% casein, 1% methionine) beginning day zero of pregnancy. Amino 
acid concentrations were determined using HPLC in maternal and fetal plasma on day 20 of 
gestation, with the exception of homocysteine, which was measured using an enzymatic method 
in maternal samples only. Results: In dams, both low protein diets were associated with elevated 
methionine and reductions in threonine. Maternal homocysteine was elevated only by the low 
protein diet with the higher level of methionine. Also in response to the low protein/ high 
methionine diet, maternal glycine, serine and proline were modestly but significantly decreased. 
Dietary effects on methionine and threonine were also seen in fetuses, except that methionine 
increases were more dramatic, and absolute concentrations of methionine were ~5-fold higher 
than in dams, even in controls. Branched chain amino acids were decreased in fetuses despite 
unaltered maternal levels. Conclusions: Protein-restricted, methionine-imbalanced diets fed 
during pregnancy affect both maternal and fetal amino acid levels. Diet effects on fetal amino 
acid profiles are not necessarily reflected in maternal plasma, but need to be considered with 




The developmental origins of health and disease hypothesis states that adaptive 
responses, also termed reprogramming events, occur in developing organisms in response to 
stimuli encountered during critical periods of development (Barker 2007). Critical periods are 
those during which a high degree of developmental plasticity occurs, such as during rapid cell 
division or the establishment of tissue-specific patterns of DNA methylation (Langley-Evans 
2006). When the uterine environment is predictive of the post-natal environment, the 
reprogramming event is adaptive. When the two environments differ, the reprogramming event 
becomes maladaptive, and the individual is predisposed to development of an array of chronic 
diseases collectively referred to as Metabolic Syndrome (Gluckman & Hanson 2004).  
 Protein restriction of rats during pregnancy has been used extensively to study 
developmental programming. In these models, isocaloric diets with casein as the protein source 
are fed for all or part of pregnancy, beginning the day after mating. Two such models, based on 
the Southampton and Hope Farms diet formulations, elicit different reprogramming effects 
despite identical feeding and mating regimes: the Southampton diet produces hypertensive 
offspring (Langley-Evans 2006) while the Hope Farms diet results in altered glucose metabolism 
(Hoet et al. 2000, Ozanne & Hales 2002) with inconsistent effects on blood pressure (Lucas et 
al. 1996, Petry et al. 1997). Even when these two regimes were compared within the same study, 
with low protein diets, each containing 9% casein, the Hope Farms formulation did not elicit 
hypertension (Langley-Evans 2000). These findings suggest that the programming effect of the 
Southampton diet involves more than protein reduction.  The Southampton and Hope Farms diets 
differ in overall content and composition of carbohydrates and fatty acids, as well as in the level 
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of supplemental DL-methionine (Langley-Evans 2000). Because casein is deficient in sulfur 
amino acids, supplementation with cystine is currently recommended (Reeves et al. 1993). Many 
laboratories continue to follow earlier recommendations and supplement with methionine, which 
can be endogenously converted to cysteine. However, it is well established that excess levels of 
methionine are toxic (Muramatsu et al. 1971, Sauberlich 1961). Within the Southampton model, 
methionine is added to both control and low protein diets at 0.5% (Supplementary Data Table 5), 
such that the low protein diet contains twice as much methionine relative to total protein as the 
corresponding control diet. With respect to the differential programming effects, the 
Southampton low protein diet (LPD) contains 2.5-fold and 6-fold more supplemental methionine 
than Hope Farms control (22% casein, 0.2% methionine) and low protein diets (9% casein, 
0.08% methionine), respectively. Thus, disruption of methionine metabolism may play a role in 
developmental reprogramming (Langley-Evans 2000).  
 Methionine is an essential sulfur amino acid that plays a key role in one-carbon 
metabolism as well as in protein synthesis (Fig. 1). One-carbon metabolism, encompassing the 
methionine and folate cycles, is the transfer of single-carbon moieties between different 
molecules, such as during the methylation of DNA (Cho et al. 2007). Altered methionine levels 
could easily disturb the delicate balance of such one-carbon transfers leading to reprogrammed 
offspring (Cooney et al. 2002, Lillycrop et al. 2005, MacLennan et al. 2004). Ingested 
methionine enters the methionine cycle and is adenylated to S-adenosylmethionine (AdoMet) 
(Reaction 1 Fig. 1), the ultimate methyl donor for cellular methylation reactions 
(transmethylation). After donation of its methyl group during transmethylation, AdoMet is 
converted to S-adenosylhomocysteine (AdoHcy) (Reaction 2 Fig. 1), a potent inhibitor of 
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transmethylation. The ratio of AdoMet: AdoHcy is used as an indicator of methylation capacity 
(Finkelstein 2000, Finkelstein 2007). Studies have shown that altered methionine levels change 
this ratio and alter gene methylation with resultant changes in gene expression (Pogribny et al. 
2006, Pogribny et al. 2008, Jiang et al. 2007). Thus increased methionine in the Southampton 
LPD could alter gene methylation and expression leading to the observed hypertensive 
phenotype in LPD offspring (Rees et al. 2000, Lillycrop et al. 2005). 
 Alterations in dietary methionine content may also elicit hypertensive offspring by 
increasing levels of the non-protein amino acid homocysteine (Rees et al. 2000, Petrie et al. 
2002). Homocysteine is formed from the hydrolysis of AdoHcy within the methionine cycle 
(Reaction 3 Fig. 1). However, the reverse reaction, formation of AdoHcy from homocysteine, is 
more favourable thermodynamically. To ensure continued AdoHcy hydrolysis and thus 
continued transmethylation, homocysteine must be removed from the cell. One route achieving 
this is a folate-dependent remethylation of homocysteine to methionine (Reaction 7 Fig. 1), thus 
completing the methionine cycle. This reaction is contingent upon an adequate folate supply. 
Alternatively homocysteine can be converted to cysteine and eventually taurine and glutathione, 
via an irreversible serine-dependent condensation forming cystathionine in a process termed 
transsulfuration (Reaction 4 Fig. 1) (Finkelstein 1998, Eskes 1998). Excess methionine has been 
shown to increase circulating homocysteine levels, thus implying that cellular clearance capacity 
has been surpassed (Hoffer 2004, Zhang et al. 2004). Increases in circulating homocysteine have 
been associated with a number of adverse health conditions including cardiovascular disease 
(Ueland et al. 2000). On day 4 and 20 of gestation, dams fed the Southampton LPD have been 
reported to have increased circulating homocysteine levels.  Thus, absolute or relative excesses 
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of methionine leading to elevations in homocysteine may contribute to programming via direct 
effects on developing vasculature (Petrie et al. 2002, Brawley et al. 2004).  
 The objective of this study was to assess maternal and fetal plasma amino acid profiles in 
the context of the Southampton model: pregnant rats were fed casein-based diets with normal 
versus low protein levels (18% and 9% casein, respectively), supplemented with the same level 
of methionine (0.5%). A third diet (9% casein, 1% methionine) was included to produce a 
definitive methionine excess. We hypothesized that the combination of low-protein and high-
methionine would increase maternal plasma levels of homocysteine, which would result in 
increased transsulfuration and elevations of downstream sulfur amino acid metabolites in dams 
and fetuses.    
2.3 Materials and methods 
2.3.1  Animals and Diets 
All experimental procedures were approved by the University of Waterloo Animal Care 
Committee and complied with the guidelines of the Canadian Council on Animal Care.  Prior to 
mating, all rats were maintained on grain-based standard rodent chow (Harlan Teklad, Global 
2018, 18.6% protein). At 12-20 weeks of age, virgin female Wistar rats were housed overnight 
with a male of the same strain. Upon detection of a vaginal plug, denoted as day zero of 
pregnancy, females were weighed and allocated to one of the three dietary treatments. The dams 
were maintained on their experimental diets, consumed ad libitum, until they were killed on day 
20 of gestation. Food consumption was monitored.  
Two of the experimental diets (CON, LP) were designed to replicate those described 
previously by Langley-Evans et al. (2000). The second low-protein high-methionine diet (LP-
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MET), which was supplemented with higher methionine, was intended to produce a methionine 
excess that would disrupt the methionine cycle while avoiding overt toxicity and pregnancy 
loss. The control diet contained 180 g casein/kg diet and 5 g/kg supplemental DL-methionine. 
The low-protein diets (LP and LP-MET) both contained 90 g casein/kg diet, with supplemental 
DL-methionine provided at 5 and 10 g/kg diet respectively. Experimental low protein diets were 
held iso-caloric to the control by increasing sucrose and corn starch (Supplementary Data Table 
5). All comparisons were relative to the 18% casein diet (CON). 
2.3.2 Sample Collection 
Dams were killed by carbon dioxide asphyxiation and weighed. Maternal blood was 
collected into EDTA-coated tubes by cardiac puncture, and stored on ice. The feto-placental unit 
was rapidly removed and the five fetuses in each horn closest to the cervix were removed for 
sampling. Fetuses were gently blotted dry on filter paper, sexed via measurement of ano-genital 
distance, then exsanguinated via decapitation. The blood was placed on ice until being 
centrifuged at 2500 x g for 20 min at 4ºC. Plasma was collected and stored at -20ºC until 
analysis. 
2.3.3  Amino Acid Analysis 
Quantification of free amino acids in maternal and fetal plasma was performed by HPLC, 
with the exception of homocysteine. Briefly, plasma and the internal standard (6 mM norleucine) 
were combined and the mixtures deproteinized by centrifugation at 12,000 x g for 15 min in 
centrifugal filters (Microcon Rose-YM 50, Fisher Scientific, Ottawa, ON, Canada).  Filtrates 
were collected and evaporated to dryness. Pre-column derivatization with phenylisothiocyanate 
was carried out according to the manufacturer’s protocol (PicoTag, Waters, Milford, MA, USA), 
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after which derivatized samples were stored at -20ºC until analysis. Chromatographic separation 
was performed using sample injection volumes of 40 µL, a PicoTag reversed-phase column (30 
cm by 3.9 mm i.d.), and a gradient of sodium acetate-acetonitrile buffer (as described in the 
PicoTag protocol) with UV detection at 254 nm. Chromatograms were analyzed with the 
Millenium 32 software (Waters). 
Homocysteine  concentrations were determined using a kit (Diazyme, Poway, California) 
based on an enzyme cycling approach, in which homocysteine quantification was achieved via 
spectrophotometric monitoring of NAD
+
 levels. Volumes of fetal plasma remaining after HPLC 
analysis were insufficient to measure homocysteine. 
2.3.4 Statistical Analysis 
All statistical analyses were performed using SAS for Windows, version 9 (SAS Canada, 
Toronto, ON). The number of litters per diet ranged from 8 to 9, with 3 to 19 pups per litter.  
Effects of diet on maternal endpoints (weight gain, feed intake, litter size, plasma amino 
acids) were analyzed by one-way ANOVA, and analyses significant at p<0.05 were followed by 
posthoc comparisons using the Tukey adjustment for multiple comparisons. 
Because fetuses from the same litter share both genetics and a common intrauterine 
environment, it would be incorrect to consider littermates independent observations. For this 
reason, fetal endpoints (fetal weight, plasma amino acid concentrations) were analyzed using a 
mixed model ANOVA, with diet and fetal sex as fixed effects and litter as a random effect.  
Because fetal sex had no effect on plasma amino acids it was dropped from the model for those 
analyses. As before, posthoc comparisons using the Tukey adjustment were performed when 
main effects were significant at P<0.05. To reflect the fact that litter was nested within diet, the 
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litter(diet) mean square was used as the error term for these comparisons, and results are 
presented as least squares means. 
2.4 Results 
2.4.1 Effects of Diet on Pregnancy Outcome 
 Four animals (control, two; LP, one; LP-MET, one) found not to be pregnant on day 20 
were dropped from the study. One of them showed signs of fetal resorption; it was presumed that 
the other three dams were never pregnant. Abnormalities were noted in two of eight CON litters, 
two of eight LP litters and three of nine LP-MET litters. In the CON group, these consisted of 
blood clots in three fetuses and three hemorrhagic placentas (one of which corresponded to one 
of the aforementioned fetuses). In the LP group one enlarged, conjoined placenta and one fetus 
with abdominal hemorrhaging were observed. In the LP-MET group, three dams displayed 
asymmetric implantation patterns, favouring implantation in the left uterine horn with litter sizes 
of 10, 3 and 7 fetuses for these dams. However, the resulting decrease in average litter size for 
this group (Table 1) did not reach statistical significance. 
Maternal weight gain, food consumption and fetal data for the three dietary groups are 
shown in Table 4. Food consumption of dams (482 ± 101 g, over all three diets) was not affected 
by diet. Although not reaching statistical significance, there was a tendency for dams consuming 




Table 4: Maternal weight gain, food intake, litter sizes and fetal weights on day 20 of 
gestation following consumption of diets varying in methionine and protein content*. 
Diet CON (n=8) LP (n=8) LP-MET (n=9) 
Maternal food intake (g) 
Maternal weight gain (g) 
511 ± 19 
158 ± 9 
463 ± 35 
158 ± 10 
470 ± 19 
123 ± 10 
Litter size 14 ± 1 15 ± 1 12 ± 2 
Fetal weight (g)† 3.44 ± 0.37 3.45 ± 0.39 3.36 ± 0.33 
    Fetal weight, male (g) 3.55 ± 0.06 3.48 ± 0.06 3.44 ± 0.10 
    Fetal weight, female (g) 3.22 ± 0.09 3.49 ± 0.07 3.29 ± 0.07 
*Key differences in diets:  CON (control) - 18% casein / 0.5% Met; LP (low protein) - 
9% casein/ 0.5% Met; LP-MET - 9% casein / 1% Met 
†Values are means ± SEM, except for fetal weights, which are presented as least squares 
means to reflect the fact that ‘litter’ was included as a random effect in the analysis of 
variance. 
There were no significant diet effects on any of these endpoints at P < 0.05. 
 
 
The slightly reduced litter size observed in the LP-MET group (attributable to the two 
aforementioned litters of 3 and 7 fetuses) was not enough to reach statistical significance (overall  
average of 14 ± 0.7 fetuses/ dam). Fetal weight showed no dietary effect (average 3.4 g ± 0.2). 
Regardless of diet, male fetuses were heavier than females (Table 4, p<0.01). Female and male 
fetuses were respectively found to have typical ano-genital distances of 1.2 mm (or less) or of 1.8 
mm (or greater).  
2.4.2 Effects of Diet on Plasma Amino Acid Concentrations 
 Data for selected sulfur amino acids are presented in Fig. 3. Regardless of diet, 
methionine and taurine were the most abundant sulfur amino acids in both maternal and fetal 
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plasma. This was particularly marked in fetal samples, in which concentrations of methionine 
and taurine were, respectively, 3-5 and 8-9 fold higher than in maternal plasma. Methionine and 
homocysteine were the only sulfur amino acids affected by diet. Interestingly, the two low-
protein diets increased methionine concentrations in maternal plasma to the same extent despite 
the two-fold difference in their methionine contents (P<0.01; Fig. 3A). In contrast, maternal 
 
Figure 3: Concentrations of selected sulfur amino acids in (A) maternal and (B) fetal 
plasma on day 20 of gestation following consumption of diets varying in methionine and 
protein content. 
Key differences in diet composition are noted below Table 1.  Maternal data are presented as 
arithmetic means ± SEM, while fetal values are least squares means ± SEM to reflect the fact 
that ‘litter’ was included as a random effect in the analysis of variance.  Note the difference in 
scales that was required to accommodate the high concentrations of methionine and taurine in 
fetal plasma. For dams: control n 6, LP n 5, LP-MET n 6. For fetuses: control n 44, LP n 47, LP-
MET n 49. *Significantly different from CON (p<0.01).  **Significantly different from CON 
(p<0.001).  ¢Significantly different from both CON and LP (p<0.05).  ND = not determined due 




homocysteine levels were increased by the LP-MET diet but not by the LP diet formulated 
according to the Southampton model (P<0.001; Fig. 2A). In fetal plasma, methionine 
concentrations were not affected by the LP diet, but were increased 2.2-fold by the LP-MET diet 
(P<0.05; Fig. 3B). Homocysteine levels in fetal plasma were not determined due to insufficient 
sample volume.
 
Figure 4: Concentrations of selected non-sulfur amino acids in (A) maternal and (B) fetal 
plasma on day 20 of gestation following maternal consumption of diets varying in 
methionine and protein content. 
  Key differences in diet composition are noted below Table 1.  Maternal data are presented as 
arithmetic means ± SEM, while fetal values are least squares means to reflect the fact that ‘litter’ 
was included as a random effect in the analysis of variance. For dams: control n 6, LP n 5, LP-
MET n 6. For fetuses: control n 44, LP n 47, LP-MET n 49. *Significantly different from CON 
(p<0.01).  †Significantly different from CON (p<0.0001).  ‡Significantly different from CON 




Data for non-sulfur amino acids affected by diet are shown in Fig. 4. The most dramatic 
dietary effect on non-sulfur amino acids was a decrease in plasma threonine in both maternal 
(Fig. 4A) and fetal plasma (Fig. 4B) in response to both LP and LP-MET diets. Other non-sulfur 
amino acids were differentially affected in dams and fetuses. In maternal plasma, reductions in 
serine and proline were observed as dietary protein decreased and methionine increased.
 
Figure 5: Ratios of mean fetal : maternal plasma amino acid concentrations at day 20 of 
gestation across all diets (least squares means to reflect adjustment for litter effects). 
Amino acids were enriched in fetal plasma, with the exceptions of proline (equal to maternal 
concentrations).  Fetal : maternal ratios were not affected by diet (P>0.05). 
 
Ratios of fetal to maternal amino acid concentrations are shown in Fig. 5. Because these 
ratios were not affected by diet, a ratio was calculated for each fetus relative to its dam, and a 
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single average was presented across all three diets for each amino acid. With the exceptions of 
proline (similar in fetal and maternal plasma), all amino acids were more highly concentrated in 
fetal plasma. Nine amino acids, including methionine, were highly enriched (4 to 11-fold higher 
in fetal plasma), eight amino acids, including the branched chain amino acids, were moderately 
(2 to 4-fold) enriched, and five amino acids were slightly (less than 2-fold) higher in fetal 
plasma. 
2.5 Discussion 
 Although the Southampton model of developmental programming is referred to as 
‘protein restriction’ or ‘low protein diet’, evidence from several studies has suggested that 
disruption of one-carbon metabolism may lie at the heart of the programming phenomenon (Rees 
et al. 2006c). Specifically, the elevated ratio of supplemental methionine to dietary protein has 
been called into question. A relative excess of methionine leading to increases in circulating 
homocysteine could disrupt cellular methylation reactions, resulting in an altered epi-genotype 
and developmental reprogramming. This study sought to characterize the effects of low protein 
diets with elevated supplemental methionine on plasma amino acid profiles in dams and fetuses 
late in gestation. In agreement with most studies using the Southampton protocol, pregnant rats 
consuming the protein-restricted diets displayed a remarkable ability to produce offspring of 
normal weight and number, without alterations in weight gain or feed intake (Brawley et al. 
2004, Langley-Evans et al. 2006, Torrens et al. 2006, Engeham et al. 2010). In dams, both low 
protein diets were associated with elevated methionine and marked reductions in threonine. In 
response to the higher level of methionine supplementation, maternal homocysteine levels 
doubled while glycine, serine and proline were modestly but significantly decreased. In fetuses, 
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effects of the low protein diets on methionine and threonine were also evident. Methionine was 
among the amino acids highly enriched in fetal plasma, such that fetal levels were nearly 5-fold 
higher than maternal levels, even in controls.   
Both low-protein diets elicited significant increases in maternal plasma methionine 
levels. To our knowledge, this is the first study to assess plasma methionine using the 
Southampton protocol, wherein experimental diets are fed beginning day zero of pregnancy.  
However, several studies in which these same diets are initiated two weeks prior to mating have 
reported no effect on maternal methionine (Petrie et al. 2002, Rees et al. 1999, Rees et al. 
2006a). This two week period prior to pregnancy may permit adaptation via the hepatic enzyme 
methionine adenosyl transferase (Finkelstein 2000), which has been shown to be upregulated by 
excess dietary methionine (Finkelstein & Martin 1986). Interestingly, the magnitude of 
methionine elevation in dams fed low-protein diets was the same despite a 2-fold difference in 
dietary methionine supplementation. This observation suggests that these dietary effects cannot 
be explained by an accumulation of un-metabolized diet-derived methionine in maternal plasma. 
Maternal plasma homocysteine levels were substantially elevated by the low protein, 1% 
methionine diet, but not within the context of the Southampton model (control versus low 
protein, both at 0.5% methionine). Unaltered maternal homocysteine by day 20 of pregnancy, 
which is consistent with previous reports (Langley-Evans et al. 2006, Petrie et al. 2002), does 
not negate the possibility of altered one-carbon metabolism as a programming mechanism.  
Firstly, programming effects may be mediated by early gestation rises in homocysteine, such as 
that reported by Petrie and coworkers (day 4, (Petrie et al. 2002). The normal levels of maternal 
homocysteine by day 20 ((Petrie et al. 2002), current study) may reflect increased catabolism and 
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clearance. To this point, cystathionine and taurine levels were unaffected, suggesting that 
homocysteine catabolism via transsulfuration was not altered by diet. An increased reliance on 
homocysteine remethylation, at least in dams, is a plausible explanation for the maintenance of 
normal homocysteine levels. Furthermore, while low-protein fed dams ingesting 0.5% 
supplemental methionine (Southampton model) appear to have sufficient methyl donors to 
maintain control homocysteine values, feeding of 1% supplemental methionine may exhaust the 
available methyl donor supply. Thus, the feeding of low-protein, methionine-unbalanced diets 
such as the Southampton LPD may perturb folate and/ or betaine (choline) metabolism via an 
increased demand for methyl donors for homocysteine remethylation. 
Diet-associated alterations in fetal amino acid profiles may have been indirect effects of 
increased maternal methionine levels on competition for placental transport. Maternal 
consumption of low-protein diets containing 0.5% and 1% methionine caused the already high 
levels of methionine in fetal plasma to rise 1.4 and 2.2 fold, respectively. The greater increase in 
fetal levels with 1% versus 0.5% maternal methionine supplementation was particularly 
interesting given that maternal plasma methionine was not different in these two groups. 
Decreases in fetal levels of all three BCAA (leucine, isoleucine, valine) and threonine were also 
observed. Competition amongst several of the neutral amino acids for placental transport has 
been suggested (Tsitsiou et al. 2009). Expressed on the maternal and fetal trophoblast surfaces, 
System L transports a wide range of neutral amino acids, including the BCAA and methionine 
(reviewed in (Regnault et al. 2005)). Methionine, homocysteine and leucine have been shown to 
compete with near equal affinity for placental System L transport in vitro. Studies in sheep have 
shown that maternal infusion of a mixture of nine essential amino acids did not increase 
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circulating fetal threonine levels, but did result in a 3.5 fold increase in fetal plasma methionine 
(Jóźwik et al. 2004).  Furthermore, eight amino acids not in the infusion mix actually decreased 
in fetal blood (Jóźwik et al. 2004). Infusion of only threonine elicited increased fetal threonine 
seemingly at the expense of fetal BCAAs, which decreased (Paolini et al. 2003). If competition 
for transport can occur under those conditions, it is possible that the nearly 2-fold increase in 
maternal methionine levels in the low-protein groups could have contributed to the reductions of 
BCAA in fetal plasma. This possibility is supported by our finding that decreases in BCAA were 
only significant in the fetuses from dams receiving the higher methionine supplement (LP-MET 
diet). This is the first study reporting fetal plasma amino acid levels for the Southampton diet 
model.  Although more in-depth investigation is required to bring clarity to these findings, it is 
clear that alterations in maternal nutrient consumption could have unexpected effects on fetal 
nutrient supply.  
In rats there are surprisingly few reports of amino acid profiles in fetal blood, and 
particularly fetal : maternal amino acid ratios in matched samples. In agreement with two 
previous reports in late gestation rats (Palou et al. 1977, Malandro et al. 1996), the three most 
abundant amino acids in rat fetal plasma in the present study were glutamine, alanine and lysine. 
The same three amino acids are also the most abundant in human fetal blood at 12-17 weeks 
(cardiac puncture (Jauniaux et al. 1999)) and term (umbilical venous samples (Jauniaux et al. 
2001)). Of the nine amino acids in the present study that were highly enriched in fetal blood 
relative to maternal blood, seven were also the most enriched in the rat study of Malandro and 
coworkers ((Malandro et al. 1996), the other two amino acids were not quantified). However, our 
ratios were generally higher. For example, we observed a fetal: maternal ratio of 4.9 for 
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methionine versus 2.4 (Malandro et al. 1996). However, we calculated their ratios posthoc, such 
that dams and fetuses were not matched and fetal blood samples may have even been pooled. 
Our ratios were less similar to those reported in humans. In agreement with the present study, 
aspartate, taurine, arginine, tyrosine, methionine and phenylalanine were among the highly 
enriched amino acids in human fetal blood at 12-17 weeks gestation, with ratios ranging from 2.1 
to 3 (Jauniaux et al. 1999). However, ornithine and lysine, which were the most enriched in the 
human, were only slightly enriched in rat fetal blood. 
Modest reductions in glycine, serine and proline, and a marked reduction in threonine 
occurred in dams fed the low-protein high-methionine test diets. Decreases in maternal threonine 
concentrations have also been reported in studies using the Southampton diet formulations 
beginning two weeks prior to mating (Rees et al. 1999, Rees et al. 2000, Petrie et al. 2002, Rees 
et al. 2006a). Because the magnitude of the threonine decrease was proportional to the reduction 
in dietary protein content, it is tempting to attribute this to a simple deficiency of this essential 
amino acid. Indeed, once the sulfur amino acid (specifically cysteine) deficiency is rectified by 
the addition of methionine (Harper 1959, Reeves et al. 1993), threonine becomes the next 
limiting amino acid in casein-based diets. Inclusion of another group (18% casein with 1% 
methionine) would have resolved the role of reduced protein versus elevated methionine. 
Support, however, for increased dietary methionine as the etiology for threonine reduction lies in 
the a fact that tryptophan, the third most limiting amino acid in casein (Harper 1959), did not 
differ according to diet.  Increased utilization of threonine, glycine and serine for 
gluconeogenesis is unlikely, since control and test diets were isocaloric. Additionally, changes in 
other key gluconeogenic amino acids such as alanine and glutamine were not observed. Thus 
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another explanation must underlie the observed decreases in threonine, glycine, serine and 
proline.   
The reductions in threonine could be rooted in increased enzymatic catabolism via serine-
threonine dehydratase (SDH) or threonine dehydrogenase (TDH). Although the main activity of 
SDH is oxidation of threonine and serine to their respective α-ketoacids ((House et al. 2001); 
Fig. 2), it may also catalyze the condensation of homocysteine and serine to form cystathionine 
(Selim & Greenberg 1959, Selim & Greenberg 1960, Goldstein et al. 1962). This CBS-activity 
of SDH would link methionine and threonine metabolism, possibly explaining the increased 
SDH activity and reduced threonine levels observed in response to high-methionine diets (Daniel 
& Waisman 1969, Girard-Globa et al. 1972, Sanchez & Swendseid 1969). Increased SDH 
activity however seems improbable in the current study, as cystathionine and taurine levels were 
unaffected. The changes in our maternal amino acid profiles do raise the possibility of increased 
TDH activity in response to low-protein high-methionine diets. Threonine oxidation by TDH 
yields glycine ((House et al. 2001); Fig. 2). Glycine can be further used for synthesis of 
structural molecules, and like serine, can be used to regenerate methylene-tetrahydrofolate, and 
by extension methyl-THF (Friesen et al. 2007). Increased folate requirements during pregnancy 
are commonly accepted, owing to increased nucleotide synthesis and cellular replication (Antony 
2007). It thus becomes interesting that threonine reduction in response to Southampton low-
protein diet feeding occurs only in pregnant rats, and not their non-pregnant counterparts (Rees 
et al. 2006a). Indeed, the equivalently increased methionine in dams fed the low-protein diets 
with 0.5% or 1% methionine in the present study, along with elevations in homocysteine in the 
latter group raise questions regarding folate flux in these animals, questions furthered by the 
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decreases in threonine, serine and glycine observed. Moreover, impairment of folate cycling in 
this model is supported by reports showing that supplementation of the Southampton low-protein 
diet with folate prevents programming effects on blood pressure (Torrens et al. 2006), epigenetic 
alterations in hepatic gene expression (Lillycrop et al. 2005), and preferences for fatty foods 
(Engeham et al. 2010).  
The notion that the reprogramming effects of the Southampton model involve disrupted 
one-carbon metabolism arising from excess dietary methionine has been debated for some time 
(Rees et al. 2006c, Langley-Evans et al. 2006). Lack of dietary effects on a number of metabolic 
endpoints, including plasma homocysteine late in gestation and expression of methionine 
synthase mRNA in maternal liver has led one group to conclude that disruption of methionine-
homocysteine metabolism is not involved (Langley-Evans et al. 2006, Engeham et al. 2010). 
This issue may prove to be surprisingly difficult to resolve given that maternal liver, fetal liver 
and placenta may play varying roles depending on gestational stage, and many of the key 
metabolites are not readily measureable in extracellular fluid. Moreover, reprogramming may 
have been already set in motion by the transient perturbations in maternal homocysteine levels, 
and possibly one-carbon metabolism, during the pre-implantation period (Petrie et al. 2002, 
Kwong et al. 2000), well before the development of the placenta or the fetal liver. From mid-
gestation onwards, the placenta may be a more active participant in the methionine and folate 
cycles than previously believed. It was recently shown that term human placenta expressed 
mRNA for methionine synthase and methylene-THF reductase at levels comparable to those in 
adult liver (Solanky et al. 2010). Expression of the enzymes catalyzing other pathways of 
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homocysteine catabolism was very low to undetectable, suggesting folate-dependent reactions 
may be particularly important in the placenta.   
The Southampton diet model has shed much light on mechanisms underpinning many 
aspects of developmental programming. This study confirms the changes in maternal amino 
acids reported by Rees and coworkers (Rees et al. 1999, Rees et al. 2000, Petrie et al. 2002, Rees 
et al. 2006a), and extends these observations by quantifying amino acid levels in individual 
fetuses. We found effects of the low protein / methionine-unbalanced diets on several fetal amino 
acids that were not reflected in maternal plasma. Concentrations of methionine in fetal plasma 
were 4-fold higher than maternal levels even in animals fed the control diet. The fact that fetal 
methionine concentrations rose still higher in response to the methionine-unbalanced diets raises 
the concern that the fetus’s ability to metabolize excess methionine and maintain normal one-
carbon metabolism could be overwhelmed. Altered fetal amino acid profiles are likely due to a 
combination of competitive interactions among amino acids for placental transport and shifts in 
the activities of the methionine and folate cycles in response to excess methionine. Clearly, 
effects at the fetal level are developmentally relevant and need to be considered with respect to 
the mechanisms of this model of developmental programming. 
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2.7 Supplemental Data 
Table 5: Composition of Experimental Diets  
Component (g/kg) CON 
(18% casein, 0.5% Met) 
LP 
(9% casein, 0.5% Met) 
LP-MET 
(9% casein, 1% Met) 
Casein 180.0 90.0 90.0 
DL-Methionine 5.0 5.0 10.0 
Sucrose 198.0 228.0 228.0 
Corn Starch 325.0 385.0 380.0 
Maltodextrin 95.0 95.0 95.0 
Corn Oil 100.0 100.0 100.0 
Cellulose 50.0 50.0 50.0 
Mineral Mix, AIN76 35.0 35.0 35.0 
Vitamin Mix, AIN76A 10.0 10.0 10.0 

























Table 6: Maternal plasma amino acid concentrations (µM) on day 20 of gestation. 
Diet CON (n= 6) LP (n= 5) LP-MET (n= 5) P 
Ala 732 ± 20 722 ± 56 723 ± 137 NS 
Asn 198 ± 7 167 ± 15 147 ± 26 NS 
Asp 18 ± 1 15 ± 2 13 ± 2 NS 
Gln 1964 ± 107 2008 ± 74 1852 ± 374 NS 
Glu 163 ± 19 137 ± 11 148 ± 27 NS 
Gly 80 ± 5
a
 82 ± 8
ab
 59 ± 8
c
 =0.05 
Ser 198 ± 7
a
 167 ± 15
ab
 147 ± 26
b
 <0.05 
Thr 356 ± 24
a
 187 ± 24
b
 151 ± 19
b
 <0.0001 
Pro 584 ± 51
a
 521 ± 27
ab
 418 ± 45
b
 <0.05 
Hyp 195 ± 4 168 ± 16 130 ± 26 NS 
Arg 101 ± 6 95 ± 7 88 ± 14 NS 
Lys 914 ± 115 864 ± 91 869 ± 209 NS 
Orn 24 ± 3 21 ± 2 25 ± 6 NS 
Ile 72 ± 8 62 ± 4 62 ± 11 NS 
Leu 127 ± 14 103 ± 8 104 ± 16 NS 
Val 154 ± 15 130 ± 10 115 ± 17 NS 
Cth 40 ± 11 58 ± 9 51 ± 18 NS 
Hcy 25 ± 4
a
 26 ± 6
a
 55 ± 11
b
 <0.001 
Met 86 ± 12
a
 148 ± 23
b
 149 ± 10
b
 <0.01 
Tau 112 ± 4 155 ± 18 142 ± 22 NS 
Phe 58 ± 6 56 ± 3 54 ± 10 NS 
Trp 68 ± 6 70 ± 19 82 ± 23 NS 
Tyr 52 ± 2 40 ± 3 41 ± 7 NS 
Values shown are means ± SEM. 
a,b
Different superscripts for mean values within a row denote significant differences.  
NS, not significant.  Cth = cystathionine; Hyp = hydroxyproline 
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Table 7:  Fetal plasma amino acid concentrations (µM) on day 20 of gestation.  
Diet CON (n=44) LP (n=47) LP-MET (n=49) P 
Ala 1605 ± 68 1714 ± 75 1609 ± 57 NS 
Asn 458 ± 28 461 ± 21 488 ± 27 NS 
Asp 59 ± 5 68 ± 5 73 ± 8 NS 
Gln 3659 ± 179 4047 ± 197 4777 ± 274 NS 
Glu 858 ± 52 927 ± 48 977 ± 72 NS 
Gly 547 ± 20 548 ±  27 549 ± 28 NS 
Ser 358 ± 19 329 ± 16 323 ± 16 NS 
Thr 529 ± 31
a
 310 ± 16
b
 239 ± 13
b
 <0.01 
Pro 584 ± 35 504 ± 31 410 ± 21 NS 
Hyp 116 ± 6 108 ± 6 110 ± 6 NS 
Arg 171 ± 8 178 ± 8 194 ± 8 NS 
Lys 1183 ± 40 1042 ± 47 1052 ±36 NS 
Orn 37s ± 2 46 ± 3 33 ± 1 NS 
Ile 149 ± 5
a
 136 ± 5
ab
 118 ± 4
b
 <0.01 
Leu 315 ± 10
a
 282 ± 10
ab 
 252 ± 7
b
 <0.01 
Val 428 ± 16
a
 385 ± 14
ab
 338 ± 9
b
 <0.01 
Cth 94 ± 18 38 ± 4 48 ± 9 NS 




 749 ± 39
c
 <0.05 
Tau 968 ± 52 1173 ± 62 1350 ± 82 NS 
Phe 232 ± 8 250 ± 10 237 ± 7 NS 
Trp 194 ± 16 167 ± 11 166 ± 22 NS 
Tyr 256 ± 10 253 ± 11 222 ± 7 NS 
Values shown are least squares means ± SEM to reflect the fact that ‘litter’ was included as a 
random effect in the analysis of variance.   
a,b,c
Different superscripts for mean values within a row denote significant differences.  






 Feeding pregnant rats protein-restricted diets has been established to elicit fetal 
reprogramming and post-natal disease (Langley-Evans 2000). The Southampton low-protein diet 
leads to offspring that develop hypertension by weaning. Presently, disagreement exists 
regarding the mechanism of programming, specifically the level of methionine provided in the 
low-protein diet, and the impact it may have on disrupting one-carbon metabolism (Rees et al. 
2006c).  
 Through the use of three iso-caloric casein-based diets, this study sought to clarify 
whether low-protein methionine-imbalanced diets affect amino acid and one-carbon metabolism 
in both dams and fetuses. Two diets (Control and Low-Protein) were designed to exactly 
replicate the Southampton model diets, containing 18% and 9% casein respectively, with a 
constant supplement of 0.5% methionine. A second protein-restricted diet (Low-Protein High-
Methionine) containing 9% casein and 1.0% supplemental methionine, was employed to serve as 
a positive control for methionine stress.  
 Picotag HPLC analysis was employed to quantitate free plasma amino acids from both 
dams and fetuses, including the sulfur-based amino acids methionine, cystathionine and taurine. 
This analysis allowed an assessment of certain aspects of one-carbon metabolism, specifically 
the transsulfuration pathway (via cystathionine and taurine measurement) and the methionine 
cycle (via methionine measurement). Disturbances of both non-sulfur and sulfur-based amino 
acid metabolism were revealed, with marked elevations occurring in circulating methionine 
levels in dams and fetuses. Transsulfuration flux was not altered by diet in either dams or fetuses.   
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 Circulating homocysteine was measured in dams via a spectrophotometric-based assay. 
Although the Picotag methodology of free amino acid analysis allows superior sensitivity 
(quantification of picomolar amounts vs. nanomolar) over other methods (Anders 2002), it is not 
the best method for quantification of amino acids containing free sulfhydryl groups (i.e. cysteine 
and homocysteine) (Tyler 2000). For this reason, a well-established commercially available kit 
(Diazyme, Poway, California) was employed for homocysteine measurement.  
Evidence of disruption of one-carbon metabolism was found in dams ingesting either 
low-protein diet. Dams of both groups had significant and equal elevations of circulating 
methionine, despite the higher methionine supplement in the low-protein high-methionine group. 
Interestingly, circulating homocysteine levels were also significantly elevated within dams of the 
low-protein high-methionine group. In combination, these results indicate an increased reliance 
on methyl-donors (either from the folate cycle or choline metabolism) to support increased 
remethylation of homocysteine to methionine. While the Southampton low-protein diet appears 
capable of maintaining control levels of homocysteine via this route, the elevations in both 
methionine and homocysteine indicate that the low-protein high-methionine diet cannot. 
Although several metabolites of folate and choline metabolism were not found to be affected in 
fetuses of Southampton-fed dams (Engeham et al. 2010), this does not negate the possibility that 
flux through either of these routes could increase in response to the low-protein Southampton 
diet. Measurement of methionine synthase and BHMT activity could help resolve this issue.  
This project sought to measure hepatic AdoMet and AdoHcy levels in both dams and 
fetuses, however this was not feasible due to technical difficulties and instrument limitations. As 
of yet, AdoMet and AdoHcy levels remain unmeasured in this model. The increased levels of 
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plasma methionine observed in the present study indicate a strong possibility of disruptions to 
the AdoMet: AdoHcy ratio, a key ratio for control of gene expression. Indeed, in response to 
high methionine levels activity of the enzyme hepatic methionine adenosyltransferase has been 
reported to increase, converting methionine to AdoMet (Finkelstein & Martin 1986). Alterations 
in the levels of AdoMet and AdoHcy could explain the changes in gene expression observed 
with Southampton diet feeding and could be the mechanism behind fetal re-programming 
(Lillycrop et al. 2005, Rees et al. 2000, Lillycrop et al. 2007).  
Changes of free circulating fetal amino acids in the present study, particularly methionine 
and the three branched chain amino acids (leucine, valine and isoleucine) suggest the possibility 
of disrupted placental amino acid transport in response to low-protein methionine-imbalanced 
diets. Presumably, altered maternal amino acid levels could change competition amongst amino 
acids for key transport proteins in the placenta, such as System L (Tsitsiou et al. 2009).  
Alterations in nutrient delivery could have important consequences on growth and 
organogenesis, possibly explaining the abnormal weights of truncal organs observed in fetuses 
(Rees et al. 1999, Rees et al. 2000) and pups of Southampton-fed dams (Rees et al. 1999, Rees et 
al. 2000, Kwong et al. 2000).  
 The Southampton rodent low-protein diet model is commonly used to study 
developmental programming, despite a lack of clarity regarding its underlying mechanism. To 
resolve this question, it will be important for future studies to adhere to the same experimental 
protocols – to use the same strain of rats and to commence feeding of the low-protein diet on day 
0 of pregnancy. Only once the mechanism of programming is understood can true progress be 
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Appendix A: Composition of Southampton and Hope Farms Diets 
 
 Southampton Diet Hope Farms Diet 
g/ 100g diet 18% Casein 9% Casein 22% Casein 9% Casein 
Casein 18.0 9.0 22.0 9.0 
Corn oil 10.0 10.0   
Soybean oil   4.3 4.3 
Starch 42.5 48.5 8.0 8.0 
Glucose   53.7 66.7 
Sucrose 21.3 24.3   
DL-Methionine 0.5 0.5 0.2 0.08 
Choline 0.2 0.2   
Cellulose 5.0 5.0 5.0 5.0 
Minerals and 
vitamins 





Appendix B: Composition of Casein-Based Diets 
 
g/kg diet 18-0.5 9-0.5 9-1.0 
Casein 180.0 90.0 90.0 
DL-Methionine 5.0 5.0 10.0 
Sucrose 198.0 228.0 228.0 
Corn Starch 325.0 385.0 380.0 
Maltodextrin 95.0 95.0 95.0 
Corn Oil 100.0 100.0 100.0 
Cellulose 50.0 50.0 50.0 
Mineral Mix AIN-76 35.0 35.0 35.0 
Mineral Mix AIN-
76A 
10.0 10.0 10.0 





Appendix C: Composition of Standard Rodent Chow (Teklad) 
 




Crude fiber 35.0 
DL-Methionine 4.0 
Choline 1200 mg/kg 
Folate 4 mg/kg 
Cobalamin  0.08mg/kg 
*Ingredients: Ground wheat, ground corn, wheat middlings, dehulled soybean mean, corn gluten 
meal, soybean oil, calcium carbonate, dicalcium phosphate, breweres dried yeast, iodized salt, L-
lysine, DL-methionine, choline chloride, kaolin, magnesium oxide, Vitamin E, acetate, 
menadione sodium bisulfite complex, manganous oxide, ferrous sulphate, zinc oxide, niacin, 
calcium pantothenate, copper sulphate, pyridoxine hydrochloride, riboflavin, thiamin 
mononitrate, vitamin A acetate, calcium iodate, vitamin B12 supplement, folic acid, biotin, 




Appendix D: Composition of Extra Casein-Based Diets 
 
g/ kg diet 18-1.0 9-0.25 
Casein 180.0 90.0 
DL-Methionine 10.0 2.5 
Sucrose 198.0 228.0 
Corn Starch 320.0 387.5 
Maltodextrin 95.0 95.0 
Corn Oil 100.0 100.0 
Cellulose 50.0 50.0 
Mineral Mix AIN-76 35.0 35.0 
Mineral Mix AIN-76A 10.0 10.0 





Appendix E: LC-MS Method Development 
Attempts to develop a LC-MS method for AdoMet and AdoHcy measurement have been 
ongoing within the Servos laboratory (University of Waterloo, Department of Biology) under the 
direction of Leslie Bragg and Dr. Mark Servos. Separation and detection of AdoMet and 
AdoHcy was achieved, using an Agilent 1200 high performance liquid chromatography 
instrument with a tandem API 3200 triple quadrupole ion trap mass spectrometer.  
Reverse-phase HPLC was initially tested using a C18 column, achieving poor retention 
and co-elution of AdoMet and AdoHcy. Successful separation of peaks for AdoMet and AdoHcy 
was achieved through use of a cyano-column. Several mobile phases were tested, run in both 
isocratic and gradient formats (Table 8). The best peak shapes for AdoMet and AdoHcy were 
obtained when using water: methanol: acetic acid (95:5:0.1) (mobile phase A) and methanol: 
water: acetic acid (95:5:0.1) (mobile phase B) with gradient elution. Elution involving 
simultaneous transition of A from 70% to 30% and B from 30% to 70% over a total run time of 5 
minutes produced the cleanest peaks for AdoMet and AdoHcy of several elution schemes tested. 
Despite these successes, the sensitivity for detection of AdoMet remained poor. Attempts to 
increase sensitivity (manipulation of instrument settings, different mobile phases, different 
elution protocols (isocratic, gradient, various gradient combinations of mobile phases), and 
various preparation methods of standards) were unsuccessful.  
Additionally, all commercially available AdoMet is contaminated with AdoHcy. 
Purification was attempted through solid phase extraction (SPE). Briefly, cartridges (C18, HLB, 
MCX, NH2) were pre-conditioned with methanol and water, following which AdoMet standard 
(1 g/L) was added. Cartridges were washed with 2 mL water prior to extraction. A variety of 
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extraction solutions were tested, differing only in the ratio of methanol: water. Samples were 
evaporated to dryness overnight, and then reconstituted in methanol prior to analysis by LC-MS. 
The highest levels of AdoMet purity were achieved using C18 columns and elution with a 5:95 
methanol: water solution; however this method failed to completely purify the AdoMet.  
Table 8: Mobile phases tested during LC-MS method development for measurement of 
AdoMet and AdoHcy 
Mobile phases tested Elution type 
85:15 water: methanol Isocratic 
85:15 water: methanol with 0.1% acetic acid Isocratic 
95:5:0.1 water: methanol: formic acid 
95:5:0.1 methanol: water: formic acid 
Both gradient and isocratic 
95:5 water: methanol 
95:5 acetonitrile: water 
Both gradient and isocratic 
40% methanol with 4mM ammonium acetate 




95:5:0.1 water: methanol: acetic acid 
100% acetonitrile 
Both gradient and isocratic 
95:5:0.1 water: methanol: acetic acid 
95:5:0.1 methanol: water: acetic acid 





Appendix F: Weanling Sampling Issues 
Three novel diets were to be used in this project (9-1.0 – Appendix B, 18-1.0 & 9-0.25- 
Appendix D) – there are no reports in the literature on the effects of these diets; There have 
however been reports published on the toxicity of high-methionine diets , and the impact this 
may have on pregnancy and development (Matsueda & Niiyama 1982, Muramatsu et al. 1971). 
To determine whether any of the diets had such toxic effects a subset of dams from each dietary 
treatment group were allowed to go to term and deliver. At delivery the dams were switched 
back to standard (non-casein based methionine-balanced) rodent chow (Teklad 2018 – Appendix 
C) fed on an ad libitum basis. New-born pups were to be marked, weighed and sexed within 24 
hours of delivery. Litters were culled to 10 pups of 5 males and 5 females. At weaning (21 days 
post-natal ± 2 days) pups were to be killed via carbon dioxide asphyxiation, weighed and 
sampled for plasma, livers and kidneys.  
 Originally a number between one and ten was assigned to each pup, being marked on the 
back and abdomen of the pup with a sharpie. Within 24 hours these numbers were no longer 
visible, having been removed via maternal grooming. Marking of each pup on the back and 
abdomen with henna dye was also unsuccessful- maternal grooming once again removed the 
assigned numbers within 24 hours of marking. Working with henna dye also presented additional 
logistical challenges – a period of time was necessary for the dye to set and dry. Pups had to be 
kept relatively immobile during this period (rolling caused smudging of the ink) and could not be 
placed back with the mother. This proved tedious and time-consuming for the researcher, and 
imposed stress on the dam and pups. After the purchase of a commercially available micro-tattoo 
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device (Ketchum ™), micro-tattooing of newborn toes was settled on as the method to 
permanently mark pups in a timely manner. 
 Very few pups however were able to be sampled at weaning. Independent of the marking 
method used (sharpie, henna, micro-tattoo) the dams displayed a surprising tendency to 
cannibalize the young, usually within the first week after birth. Olfactory cues play a critical role 
during rat reproduction and parenting (Burn 2008), thus fresh gloves were always worn when 
handling animals to minimize problems with scent contamination/ scent disruption. Other 
theories were tested, but none met with success. Amongst the tested methods were tattooing of 
and handling of pups by one person only at birth, acclimating the dam to the tattoo ink by 
smearing a tiny bit on her nose and fur, not tattooing the pups, and not weighing the pups, and 
not wearing scented fragrances (e.g. deodorant, cologne). After the failure of all these 
approaches an article was found showing that cage cleaning two times per week during weaning 
is enough to stress dams and elicit maternal cannibalism of pups (Burn 2008). At this point, the 
most plausible explanation for maternal cannibalism of pups seems to be frequent cage cleaning 
(every day) by the animal care technician. At the time the frequency of cage cleaning was 
discovered, no animals remained to test this theory. The average number of live pups at birth and 
weaning for each diet are presented in table 9. Also shown in the table is the average litter size 







Table 9: Summary of Maternal Cannibalism of Pups 
Diet  Live pups at birth Litter size (after 
culling) 
Live pups at 
weaning 
18-0.5 10 ± 1.8 9 ± 1.0 7 ± 2.0 
9-0.5 11 ± 2.0 9 ± 1.3 3 ± 0.3 
9-1.0* 15 ± 1.5 10 ± 0 3 ± 2.2 
18-1.0 7 ±1.6 7 ± n/a 1 ± 0.4 
9-0.25 10 ± 1.7 9 ± 2.2 7 ± 1.9 
Standard* 11 ± 3.0 8 ± 1.6 5 ± 2.0 
18-0.5, n=4; 9-0.5, n=4; 9-1.0, n=4; 18-1.0, n=4; 9-0.25, n=3; STD, n=3 
*One dam from each of these groups was acclimated to the micro-tattoo ink as described above. 
Pups from these litters were still eaten by the mother.  
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